−£1.34m
vs Jul 2024Active08949503Private limited companyLiverpool
EXTENTUS PHARMA LTD
D39/10001
Summary
EXTENTUS PHARMA LTD is an active private limited company (company number 08949503) incorporated on 20 March 2014, registered in Liverpool. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest small accounts cover the period ending 31 July 2025, showing net assets of −£1.34m and cash of £200k, with 3 employees on average. Net assets fell 4% on the prior period (−£1.29m).
Peer position · net assets
By net assets it sits in the bottom quarter of 2,418 comparable companies in the UK (median £1,000, upper quartile £92k).
02
Key dates
- Incorporated
- 20 March 201412 yrs ago
- Next accounts due
- 30 April 2027in 190 days
- Confirmation statement due
- 3 April 2027in 163 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
03
Activity
- SIC 72110
- Research and experimental development on biotechnology
- Accounts type
- Total Exemption Full
- Size band
- MicroCompanies Act thresholds
04
Financials
£200k
−13%vs Jul 2024Not reported
3
+50%vs Jul 2024| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 31 July 2025 | −£1.34m | £200k | £24k | £902k | — | — | 3 |
| 31 July 2024 | −£1.29m | £231k | £29k | £883k | — | — | 2 |
Current ratio0.25Current liabilities exceed current assets
Cash per employee£67kCash ÷ average employees
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.
05
Firmoscan score
39 / 100 · grade D
| 50 | Starting scoreEvery scored company starts here |
| −15 | Negative net assetsNet assets £-1,343,013 at 2025-07-31 |
| −8 | Current liabilities exceed current assetsCurrent ratio 0.25 |
| +4 | Cash reservesCash £200,212 |
| +8 | EstablishedIncorporated 2014-03-20 (13 years) |
| 39 | Score, grade D |
A transparent, rules-based score from filed data only: every point lists its evidence. It is not a credit rating or advice. How the score is computed.
06
Ownership and control
- University Of Liverpool
- owns 50–75% of shares
- holds 50–75% of voting rights
- can appoint or remove directors
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents.
07
Timeline
- Next accounts duein 190 days
- Confirmation statement duein 163 days
- Accounts period endNet liabilities £1.34m · small accounts
- Accounts period endNet liabilities £1.29m · small accounts
- Incorporated
08
Similar companies in Liverpool
- OXFORD BIOANALYTICAL TESTING LIMITEDLiverpool · inc. Sept 2013
- NANO BIOSOLS LTDLiverpool · inc. Oct 2014
- LINICAL UK LIMITEDChester · inc. Nov 2014
- REACTA BIOTECH LIMITEDDeeside · inc. Jun 2013
- AGROGEN LIMITEDLiverpool · inc. Apr 2013
- DP AND MARINE ASSURANCE (UK) LIMITEDLiverpool · inc. May 2015
All companies incorporated on 20 March 2014 · in Mar 2014.
09
Reminders for EXTENTUS PHARMA LTD
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.